PDD data may be more important. PDD has the endpoint that correlates with AD results so it would be more supportive of positive AD trial results than the Rett study methinks.
scott-" I believe we will start seeing heady valuation gains"-nice post and agree--give us the complete Rett and PDD readouts--and "off to the races"--MOA confirmed !!!!!!